At a glance
Evidence for omega-3 and ADHD symptoms is mixed and does not establish a reliable treatment effect. NICE advises against offering dietary fatty-acid supplements to treat ADHD in children and young people. [1] [2] [3]
Why omega-3 has been studied in ADHD
Omega-3 is a family of fats that includes EPA and DHA. These fats have ordinary roles in the body, including as components of cell membranes. Researchers have asked whether changing intake might also affect specific ADHD outcomes, such as attention, impulsivity or how someone manages daily tasks. Those questions call for trials that compare a defined intervention with a placebo. [2] [4]
Attention can mean different things in a research paper. A computer test might measure how consistently someone responds to a signal. A parent or teacher rating can reflect patterns across a school day or week. Improvement on a particular task can be interesting even when the trial tells us little about how much difference a person notices at home or school. [2] [3]
What have individual studies found?
A 12-week randomised study of 92 children and adolescents compared high-dose EPA with placebo. The EPA group improved on one focused-attention measure, and some results were more favourable among participants who began with lower blood EPA levels. Other measures, including one related to impulsivity, favoured placebo. Findings in small subgroups are best read as questions for further study. [2]
Another placebo-controlled trial used a blend of EPA and DHA in children with moderate ADHD symptoms. Overall ADHD symptom scores fell more in the placebo group. The two trials differed in formulation and what they measured. One promising result on a particular test therefore tells us less than a consistent improvement across studies, measures and settings would. [2] [3]
How does this fit with UK guidance?
NICE recommends discussing balanced nutrition and regular activity with children, young people and adults with ADHD and their families as appropriate. Its separate recommendation for children and young people advises against using dietary fatty-acid supplementation as an ADHD treatment. Evidence from the childhood studies above has limited relevance to adults, whose daily demands and treatment decisions may differ. [1] [2] [3]
If attention or impulsivity is affecting study, work or relationships, the NHS suggests speaking with a GP about support. It helps to describe where the difficulties appear, how long they have been present and what has already made things easier or harder. A specialist may also ask about earlier experiences at school or at home. [5]
A practical focus for everyday routines
If meals are hard to organise, focus on the practical obstacle first. For example, you might keep a written list of a few easy meals, use a regular reminder to take a lunch break or put food preparation steps where you can see them. If appetite or weight changes during prescribed ADHD treatment, raise it with the clinician who manages the prescription. NICE includes monitoring appetite-related effects and growth or weight where relevant. [1] [5]
For a child, share specific examples with their school and care team. It can help to describe which routines are working, where reminders are needed and how changes in environment affect concentration. This gives the people supporting the child something concrete to work with. [1]
Common questions
Does a low omega-3 reading diagnose ADHD?
NICE describes ADHD assessment as a specialist clinical and developmental assessment that considers symptoms and their impact across settings. A fatty-acid result cannot establish that diagnosis. [1]
Where can adults ask about ADHD support?
The NHS advises speaking to your GP if attention, restlessness or impulsivity is affecting work, education or relationships. The GP can consider whether referral to an ADHD specialist would help. [5]